With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...

A recent note from Goldman Sachs has highlighted India's private defence sector opportunity, listing up to six stocks that are poised to benefit from a booming $120 billion market. One of the key ...

Earnings call PTC delivered Q1 FY26 ARR growth of 9% YoY (ex-Kepware/ThingWorx) and 13% YoY free cash flow growth, with revenue and EPS exceeding guidance. Management ...

Solid Q1 financials: Constant-currency ARR grew ~9% year-over-year excluding Kepware and ThingWorx (8.4% including them), free cash flow was $267 million (up 13% YoY), and management raised ...

With more than 15 years of experience crafting content about all aspects of personal finance, Michael Benninger knows how to identify smart moves for your money. His work has been published by Intuit, ...

Abstract: A frequency domain (FD) technique for calculating arcing faults in transmission lines is applied to obtain relaying signals. There are analyzed the transient signals in order to discover ...